

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.56969569 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.56969569 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.32086742 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.32086742 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.80796668 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.17510736 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.17510736 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.17510736 |
| 9 | kynurenine metabolic process (GO:0070189) | 6.03828193 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.00907211 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.95334412 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.85859088 |
| 13 | cysteine metabolic process (GO:0006534) | 5.84507139 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.81653763 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58727369 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.58255928 |
| 17 | urea cycle (GO:0000050) | 5.44692845 |
| 18 | urea metabolic process (GO:0019627) | 5.44692845 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 5.41289730 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.31691845 |
| 21 | homocysteine metabolic process (GO:0050667) | 5.21793528 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.18910127 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.08634279 |
| 24 | protein carboxylation (GO:0018214) | 5.07257230 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.07257230 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.06255191 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.04503091 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.01340129 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.97852881 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.94533023 |
| 31 | bile acid metabolic process (GO:0008206) | 4.92418462 |
| 32 | * alpha-amino acid catabolic process (GO:1901606) | 4.78785956 |
| 33 | * lysine catabolic process (GO:0006554) | 4.77665355 |
| 34 | * lysine metabolic process (GO:0006553) | 4.77665355 |
| 35 | regulation of complement activation (GO:0030449) | 4.77624379 |
| 36 | glycine metabolic process (GO:0006544) | 4.72056156 |
| 37 | serine family amino acid metabolic process (GO:0009069) | 4.62090719 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.59736746 |
| 39 | cellular modified amino acid catabolic process (GO:0042219) | 4.59283981 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.58991755 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.52347277 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.49031098 |
| 43 | * cellular amino acid catabolic process (GO:0009063) | 4.48721463 |
| 44 | * amino-acid betaine metabolic process (GO:0006577) | 4.47725127 |
| 45 | glutamate metabolic process (GO:0006536) | 4.47543091 |
| 46 | serine family amino acid biosynthetic process (GO:0009070) | 4.47520449 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.46236841 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.46236841 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.46236841 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.43465539 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.43465539 |
| 52 | coenzyme catabolic process (GO:0009109) | 4.41780945 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 4.36455758 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.32745410 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.32567033 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.32567033 |
| 57 | ethanol oxidation (GO:0006069) | 4.30465350 |
| 58 | amine catabolic process (GO:0009310) | 4.23562493 |
| 59 | cellular biogenic amine catabolic process (GO:0042402) | 4.23562493 |
| 60 | drug catabolic process (GO:0042737) | 4.22180577 |
| 61 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.16580896 |
| 62 | phospholipid efflux (GO:0033700) | 4.16509072 |
| 63 | cellular glucuronidation (GO:0052695) | 4.16457297 |
| 64 | benzene-containing compound metabolic process (GO:0042537) | 4.14431068 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.13763357 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 4.13418296 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 4.05579905 |
| 68 | short-chain fatty acid metabolic process (GO:0046459) | 4.02104467 |
| 69 | arginine metabolic process (GO:0006525) | 3.97582719 |
| 70 | aldehyde catabolic process (GO:0046185) | 3.93691650 |
| 71 | * organic acid catabolic process (GO:0016054) | 3.89066769 |
| 72 | * carboxylic acid catabolic process (GO:0046395) | 3.89066769 |
| 73 | acetyl-CoA metabolic process (GO:0006084) | 3.88563689 |
| 74 | urate metabolic process (GO:0046415) | 3.86787851 |
| 75 | drug transmembrane transport (GO:0006855) | 3.83943405 |
| 76 | cholesterol efflux (GO:0033344) | 3.82550341 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.81913549 |
| 78 | low-density lipoprotein particle remodeling (GO:0034374) | 3.78360092 |
| 79 | ketone body metabolic process (GO:1902224) | 3.76199101 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 3.73159714 |
| 81 | 2-oxoglutarate metabolic process (GO:0006103) | 3.72579364 |
| 82 | uronic acid metabolic process (GO:0006063) | 3.71300229 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.71300229 |
| 84 | plasma lipoprotein particle assembly (GO:0034377) | 3.70666219 |
| 85 | fibrinolysis (GO:0042730) | 3.70145222 |
| 86 | * aspartate family amino acid catabolic process (GO:0009068) | 3.64002575 |
| 87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.62486588 |
| 88 | cytolysis (GO:0019835) | 3.61724026 |
| 89 | cofactor catabolic process (GO:0051187) | 3.61601536 |
| 90 | response to nitrosative stress (GO:0051409) | 3.56647171 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.56123474 |
| 92 | monocarboxylic acid catabolic process (GO:0072329) | 3.55356488 |
| 93 | cholesterol homeostasis (GO:0042632) | 3.55211876 |
| 94 | phospholipid homeostasis (GO:0055091) | 3.54949051 |
| 95 | fatty acid beta-oxidation (GO:0006635) | 3.52058927 |
| 96 | fatty acid oxidation (GO:0019395) | 3.51269866 |
| 97 | sterol homeostasis (GO:0055092) | 3.50737134 |
| 98 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.50544590 |
| 99 | regulation of gene silencing by miRNA (GO:0060964) | 3.50544590 |
| 100 | regulation of gene silencing by RNA (GO:0060966) | 3.50544590 |
| 101 | epoxygenase P450 pathway (GO:0019373) | 3.50421810 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 3.50131194 |
| 103 | complement activation (GO:0006956) | 3.50092870 |
| 104 | presynaptic membrane assembly (GO:0097105) | 3.25564921 |
| 105 | L-serine metabolic process (GO:0006563) | 3.20423778 |
| 106 | paraxial mesoderm development (GO:0048339) | 3.14893782 |
| 107 | postsynaptic membrane organization (GO:0001941) | 2.90617753 |
| 108 | chromatin remodeling at centromere (GO:0031055) | 2.81791889 |
| 109 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.77474672 |
| 110 | lateral sprouting from an epithelium (GO:0060601) | 2.75274324 |
| 111 | presynaptic membrane organization (GO:0097090) | 2.72942184 |
| 112 | notochord development (GO:0030903) | 2.69213083 |
| 113 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.67009536 |
| 114 | behavioral response to nicotine (GO:0035095) | 2.63398908 |
| 115 | DNA strand renaturation (GO:0000733) | 2.61766516 |
| 116 | CENP-A containing nucleosome assembly (GO:0034080) | 2.61309678 |
| 117 | lung-associated mesenchyme development (GO:0060484) | 2.58763283 |
| 118 | dorsal/ventral axis specification (GO:0009950) | 2.58248234 |
| 119 | otic vesicle formation (GO:0030916) | 2.57706416 |
| 120 | nonmotile primary cilium assembly (GO:0035058) | 2.50670715 |
| 121 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.50506575 |
| 122 | limb bud formation (GO:0060174) | 2.46111304 |
| 123 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.39758506 |
| 124 | histone exchange (GO:0043486) | 2.37452789 |
| 125 | anterior/posterior axis specification, embryo (GO:0008595) | 2.37371586 |
| 126 | regulation of centriole replication (GO:0046599) | 2.33728211 |
| 127 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.30538966 |
| 128 | DNA replication checkpoint (GO:0000076) | 2.29888328 |
| 129 | replication fork processing (GO:0031297) | 2.29027094 |
| 130 | kidney morphogenesis (GO:0060993) | 2.29008216 |
| 131 | protein localization to kinetochore (GO:0034501) | 2.27695712 |
| 132 | regulation of hippo signaling (GO:0035330) | 2.27450155 |
| 133 | nucleobase catabolic process (GO:0046113) | 2.25695015 |
| 134 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.25268832 |
| 135 | DNA damage response, detection of DNA damage (GO:0042769) | 2.23394099 |
| 136 | establishment of integrated proviral latency (GO:0075713) | 2.23140750 |
| 137 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.21260016 |
| 138 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.21260016 |
| 139 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.21260016 |
| 140 | regulation of mesoderm development (GO:2000380) | 2.19942924 |
| 141 | organ growth (GO:0035265) | 2.15150016 |
| 142 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.14896318 |
| 143 | cellular response to cholesterol (GO:0071397) | 2.14050226 |
| 144 | C4-dicarboxylate transport (GO:0015740) | 2.12051698 |
| 145 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.10393619 |
| 146 | retinal ganglion cell axon guidance (GO:0031290) | 2.09393244 |
| 147 | protein K6-linked ubiquitination (GO:0085020) | 2.06970341 |
| 148 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.04827392 |
| 149 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.04827392 |
| 150 | heterochromatin organization (GO:0070828) | 2.04804389 |
| 151 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.01394208 |
| 152 | DNA replication-independent nucleosome organization (GO:0034724) | 1.98471307 |
| 153 | DNA replication-independent nucleosome assembly (GO:0006336) | 1.98471307 |
| 154 | midbrain development (GO:0030901) | 1.98079857 |
| 155 | vocalization behavior (GO:0071625) | 1.97384013 |
| 156 | embryonic pattern specification (GO:0009880) | 1.97088166 |
| 157 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 1.95823789 |
| 158 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 1.95466168 |
| 159 | somite development (GO:0061053) | 1.95217310 |
| 160 | cranial nerve development (GO:0021545) | 1.95160302 |
| 161 | negative regulation of astrocyte differentiation (GO:0048712) | 1.93690423 |
| 162 | regulation of cell fate specification (GO:0042659) | 1.93105001 |
| 163 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 1.92525784 |
| 164 | nodal signaling pathway (GO:0038092) | 1.90976050 |
| 165 | L-methionine salvage (GO:0071267) | 1.90054521 |
| 166 | L-methionine biosynthetic process (GO:0071265) | 1.90054521 |
| 167 | amino acid salvage (GO:0043102) | 1.90054521 |
| 168 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 1.88252179 |
| 169 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 1.87773850 |
| 170 | regulation of mitotic spindle checkpoint (GO:1903504) | 1.87773850 |
| 171 | developmental induction (GO:0031128) | 1.86832919 |
| 172 | spinal cord development (GO:0021510) | 1.86402811 |
| 173 | outer ear morphogenesis (GO:0042473) | 1.86344143 |
| 174 | retinal cone cell development (GO:0046549) | 1.85999295 |
| 175 | thalamus development (GO:0021794) | 1.85423744 |
| 176 | convergent extension (GO:0060026) | 1.85179009 |
| 177 | mitotic metaphase plate congression (GO:0007080) | 1.84914813 |
| 178 | oxidative demethylation (GO:0070989) | 1.84592211 |
| 179 | cellular response to sterol (GO:0036315) | 1.84330950 |
| 180 | organ induction (GO:0001759) | 1.83547820 |
| 181 | mitotic sister chromatid segregation (GO:0000070) | 1.83234194 |
| 182 | DNA replication-dependent nucleosome assembly (GO:0006335) | 1.83027684 |
| 183 | DNA replication-dependent nucleosome organization (GO:0034723) | 1.83027684 |
| 184 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 1.82942865 |
| 185 | embryonic axis specification (GO:0000578) | 1.82514566 |
| 186 | respiratory chain complex IV assembly (GO:0008535) | 1.81670484 |
| 187 | neuron cell-cell adhesion (GO:0007158) | 1.81585750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.33877362 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21076399 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.60087376 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42159456 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.16867567 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.09834376 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.87632420 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97675624 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.88409571 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.84597037 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.52070767 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.46431245 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.30015252 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26686058 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.15788059 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14062061 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10132522 |
| 18 | FUS_26573619_Chip-Seq_HEK293_Human | 2.04257773 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9560444 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.98864640 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.98479742 |
| 22 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.95161363 |
| 23 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.93316124 |
| 24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.92644969 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91737179 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.91476458 |
| 27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.84777497 |
| 28 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.84019655 |
| 29 | VDR_22108803_ChIP-Seq_LS180_Human | 1.78975063 |
| 30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.71675121 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70154690 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.69640073 |
| 33 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.69623146 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68389132 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.67092154 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62874868 |
| 37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.62869137 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53134947 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.51978831 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.47854528 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.47626301 |
| 42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45977835 |
| 43 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.45007587 |
| 44 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.43249138 |
| 45 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42597885 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.42442681 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.39888570 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38492512 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34602223 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33969507 |
| 51 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.32016519 |
| 52 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.31910017 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31205160 |
| 54 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.30118375 |
| 55 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.29959223 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.29457103 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29444788 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29274601 |
| 59 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.24589810 |
| 60 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23985223 |
| 61 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.22762529 |
| 62 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22762529 |
| 63 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22422838 |
| 64 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.22059938 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21535663 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20052095 |
| 67 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19976452 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18035541 |
| 69 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.17728947 |
| 70 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.17555725 |
| 71 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.17548076 |
| 72 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.17477649 |
| 73 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16483153 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16037028 |
| 75 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15981969 |
| 76 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15963087 |
| 77 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.15866836 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15412476 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.15218329 |
| 80 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15015496 |
| 81 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.12472715 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12446774 |
| 83 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11146857 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10246889 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09216935 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08498976 |
| 87 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08136473 |
| 88 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07818843 |
| 89 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07406598 |
| 90 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06446273 |
| 91 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05841832 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05067725 |
| 93 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.03462524 |
| 94 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02703940 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02596687 |
| 96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02338170 |
| 97 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.01974272 |
| 98 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01556914 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01210308 |
| 100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00491081 |
| 101 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.00271150 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00194131 |
| 103 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99677931 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98615661 |
| 105 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97938382 |
| 106 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97792110 |
| 107 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97150696 |
| 108 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96447229 |
| 109 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95965670 |
| 110 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.95449311 |
| 111 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94975068 |
| 112 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94293939 |
| 113 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94108122 |
| 114 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93210884 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92414215 |
| 116 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.92407577 |
| 117 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92322758 |
| 118 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.92115048 |
| 119 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91154311 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90385362 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89878414 |
| 122 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89798033 |
| 123 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89774297 |
| 124 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89471036 |
| 125 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.89138480 |
| 126 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.89028633 |
| 127 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.88942696 |
| 128 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.88796618 |
| 129 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88748207 |
| 130 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88583863 |
| 131 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88583863 |
| 132 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.88297249 |
| 133 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.87280832 |
| 134 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84603301 |
| 135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81155306 |
| 136 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79819261 |
| 137 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78668947 |
| 138 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76097659 |
| 139 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75251104 |
| 140 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74690767 |
| 141 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.73324622 |
| 142 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72273790 |
| 143 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69207720 |
| 144 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.66434495 |
| 145 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66194883 |
| 146 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.64970207 |
| 147 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64101374 |
| 148 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63835711 |
| 149 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58260812 |
| 150 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56676620 |
| 151 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55521584 |
| 152 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.55277568 |
| 153 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.54544954 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.54354227 |
| 155 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.54354227 |
| 156 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52935013 |
| 157 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51941589 |
| 158 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.51084052 |
| 159 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.50789902 |
| 160 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50359772 |
| 161 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50234922 |
| 162 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.50112498 |
| 163 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.49992234 |
| 164 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48373722 |
| 165 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48264483 |
| 166 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.47801600 |
| 167 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47627361 |
| 168 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.47578616 |
| 169 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.47557816 |
| 170 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47445754 |
| 171 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46644472 |
| 172 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46502923 |
| 173 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.45957773 |
| 174 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.44227759 |
| 175 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.43960813 |
| 176 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43740519 |
| 177 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43400191 |
| 178 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.43168559 |
| 179 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43151217 |
| 180 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42380323 |
| 181 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42068216 |
| 182 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.41987991 |
| 183 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41411694 |
| 184 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.41399257 |
| 185 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.41207932 |
| 186 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.41083539 |
| 187 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.40678555 |
| 188 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39385105 |
| 189 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.39346583 |
| 190 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.37298479 |
| 191 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.36987660 |
| 192 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.36931985 |
| 193 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.36728170 |
| 194 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.36504039 |
| 195 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.36164174 |
| 196 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.36025966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.24087264 |
| 2 | MP0005360_urolithiasis | 7.59679635 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.30702617 |
| 4 | MP0005365_abnormal_bile_salt | 6.18615432 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.93401750 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.28670688 |
| 7 | MP0003252_abnormal_bile_duct | 3.87233736 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.44567545 |
| 9 | MP0005083_abnormal_biliary_tract | 3.26445292 |
| 10 | MP0003136_yellow_coat_color | 3.25989945 |
| 11 | MP0005332_abnormal_amino_acid | 3.11558218 |
| 12 | MP0009840_abnormal_foam_cell | 3.03993221 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.84811586 |
| 14 | MP0003195_calcinosis | 2.83818676 |
| 15 | MP0010030_abnormal_orbit_morphology | 2.78744715 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.63402651 |
| 17 | MP0000566_synostosis | 2.56664190 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.41722930 |
| 19 | MP0002938_white_spotting | 2.28767344 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.05724565 |
| 21 | MP0000609_abnormal_liver_physiology | 2.04875386 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.04709972 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.99663021 |
| 24 | MP0003890_abnormal_embryonic-extraembry | 1.99203305 |
| 25 | MP0001293_anophthalmia | 1.98738619 |
| 26 | MP0003868_abnormal_feces_composition | 1.94762438 |
| 27 | MP0005377_hearing/vestibular/ear_phenot | 1.91452280 |
| 28 | MP0003878_abnormal_ear_physiology | 1.91452280 |
| 29 | MP0003941_abnormal_skin_development | 1.87371889 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.85308737 |
| 31 | MP0003937_abnormal_limbs/digits/tail_de | 1.85291807 |
| 32 | MP0002102_abnormal_ear_morphology | 1.76100026 |
| 33 | MP0003119_abnormal_digestive_system | 1.75015885 |
| 34 | MP0004133_heterotaxia | 1.73292273 |
| 35 | MP0001764_abnormal_homeostasis | 1.61999117 |
| 36 | MP0002697_abnormal_eye_size | 1.57344291 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56498108 |
| 38 | MP0003880_abnormal_central_pattern | 1.56324057 |
| 39 | MP0000778_abnormal_nervous_system | 1.54423301 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.53533635 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.51095192 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.49330052 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.47620363 |
| 44 | MP0003186_abnormal_redox_activity | 1.39858372 |
| 45 | MP0002233_abnormal_nose_morphology | 1.39712368 |
| 46 | MP0004885_abnormal_endolymph | 1.38727095 |
| 47 | MP0003011_delayed_dark_adaptation | 1.37369092 |
| 48 | MP0009697_abnormal_copulation | 1.35940533 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.35936507 |
| 50 | MP0002234_abnormal_pharynx_morphology | 1.34762606 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.34687702 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.34643828 |
| 53 | MP0003693_abnormal_embryo_hatching | 1.33562790 |
| 54 | MP0000049_abnormal_middle_ear | 1.33279102 |
| 55 | MP0003122_maternal_imprinting | 1.29846623 |
| 56 | MP0001286_abnormal_eye_development | 1.29782776 |
| 57 | MP0002736_abnormal_nociception_after | 1.29348296 |
| 58 | MP0005451_abnormal_body_composition | 1.26119266 |
| 59 | MP0001984_abnormal_olfaction | 1.25991421 |
| 60 | MP0003567_abnormal_fetal_cardiomyocyte | 1.23038473 |
| 61 | MP0002653_abnormal_ependyma_morphology | 1.21314242 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.20833136 |
| 63 | MP0001529_abnormal_vocalization | 1.20703063 |
| 64 | MP0010094_abnormal_chromosome_stability | 1.20183776 |
| 65 | MP0008058_abnormal_DNA_repair | 1.19076660 |
| 66 | MP0005253_abnormal_eye_physiology | 1.18767726 |
| 67 | MP0000598_abnormal_liver_morphology | 1.17330122 |
| 68 | MP0003755_abnormal_palate_morphology | 1.16211445 |
| 69 | MP0005647_abnormal_sex_gland | 1.12193239 |
| 70 | MP0000647_abnormal_sebaceous_gland | 1.10948050 |
| 71 | MP0008932_abnormal_embryonic_tissue | 1.09369974 |
| 72 | MP0003283_abnormal_digestive_organ | 1.09237272 |
| 73 | MP0000537_abnormal_urethra_morphology | 1.08720936 |
| 74 | MP0000631_abnormal_neuroendocrine_gland | 1.08646160 |
| 75 | MP0001346_abnormal_lacrimal_gland | 1.08624590 |
| 76 | MP0005391_vision/eye_phenotype | 1.07501479 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 1.07457762 |
| 78 | MP0003861_abnormal_nervous_system | 1.05104053 |
| 79 | MP0006276_abnormal_autonomic_nervous | 1.04159815 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.04091330 |
| 81 | MP0005084_abnormal_gallbladder_morpholo | 1.03982046 |
| 82 | MP0005220_abnormal_exocrine_pancreas | 1.03627882 |
| 83 | MP0008789_abnormal_olfactory_epithelium | 1.02887890 |
| 84 | MP0003111_abnormal_nucleus_morphology | 1.02606908 |
| 85 | MP0002111_abnormal_tail_morphology | 1.01494355 |
| 86 | MP0001486_abnormal_startle_reflex | 1.01331910 |
| 87 | MP0004272_abnormal_basement_membrane | 1.00763242 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 1.00758367 |
| 89 | MP0003938_abnormal_ear_development | 1.00199050 |
| 90 | MP0002254_reproductive_system_inflammat | 0.99806304 |
| 91 | MP0001968_abnormal_touch/_nociception | 0.99300565 |
| 92 | MP0003942_abnormal_urinary_system | 0.97869794 |
| 93 | MP0009250_abnormal_appendicular_skeleto | 0.96526831 |
| 94 | MP0003121_genomic_imprinting | 0.95972543 |
| 95 | MP0009764_decreased_sensitivity_to | 0.95273121 |
| 96 | MP0000762_abnormal_tongue_morphology | 0.94668454 |
| 97 | MP0005257_abnormal_intraocular_pressure | 0.94332849 |
| 98 | MP0005187_abnormal_penis_morphology | 0.94033286 |
| 99 | MP0000026_abnormal_inner_ear | 0.93477037 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.93062391 |
| 101 | MP0005171_absent_coat_pigmentation | 0.92811806 |
| 102 | MP0000383_abnormal_hair_follicle | 0.92312244 |
| 103 | MP0010368_abnormal_lymphatic_system | 0.92158177 |
| 104 | MP0002084_abnormal_developmental_patter | 0.91705719 |
| 105 | MP0000428_abnormal_craniofacial_morphol | 0.90754678 |
| 106 | MP0000604_amyloidosis | 0.89924434 |
| 107 | MP0005195_abnormal_posterior_eye | 0.89611792 |
| 108 | MP0006036_abnormal_mitochondrial_physio | 0.89341583 |
| 109 | MP0005423_abnormal_somatic_nervous | 0.88704414 |
| 110 | MP0002282_abnormal_trachea_morphology | 0.88622127 |
| 111 | MP0005670_abnormal_white_adipose | 0.88007879 |
| 112 | MP0005394_taste/olfaction_phenotype | 0.87977854 |
| 113 | MP0005499_abnormal_olfactory_system | 0.87977854 |
| 114 | MP0009763_increased_sensitivity_to | 0.87143463 |
| 115 | MP0000955_abnormal_spinal_cord | 0.86946166 |
| 116 | MP0002092_abnormal_eye_morphology | 0.86465464 |
| 117 | MP0002752_abnormal_somatic_nervous | 0.85272347 |
| 118 | MP0001756_abnormal_urination | 0.84435980 |
| 119 | MP0002272_abnormal_nervous_system | 0.84353269 |
| 120 | MP0009642_abnormal_blood_homeostasis | 0.83677857 |
| 121 | MP0002557_abnormal_social/conspecific_i | 0.83638371 |
| 122 | MP0002085_abnormal_embryonic_tissue | 0.82715024 |
| 123 | MP0003385_abnormal_body_wall | 0.82685601 |
| 124 | MP0009053_abnormal_anal_canal | 0.81954257 |
| 125 | MP0002184_abnormal_innervation | 0.80850370 |
| 126 | MP0001324_abnormal_eye_pigmentation | 0.78028292 |
| 127 | MP0005408_hypopigmentation | 0.77937680 |
| 128 | MP0009745_abnormal_behavioral_response | 0.77920035 |
| 129 | MP0002160_abnormal_reproductive_system | 0.77678429 |
| 130 | MP0003935_abnormal_craniofacial_develop | 0.77588590 |
| 131 | MP0001963_abnormal_hearing_physiology | 0.77078325 |
| 132 | MP0000427_abnormal_hair_cycle | 0.76971487 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.76942888 |
| 134 | MP0000569_abnormal_digit_pigmentation | 0.76675606 |
| 135 | MP0002152_abnormal_brain_morphology | 0.76564548 |
| 136 | MP0000534_abnormal_ureter_morphology | 0.76389154 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.76037764 |
| 138 | MP0008469_abnormal_protein_level | 0.73052796 |
| 139 | MP0004043_abnormal_pH_regulation | 0.68537491 |
| 140 | MP0004130_abnormal_muscle_cell | 0.68265932 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.67884012 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.67642944 |
| 143 | MP0005266_abnormal_metabolism | 0.65903925 |
| 144 | MP0002971_abnormal_brown_adipose | 0.65335418 |
| 145 | MP0005535_abnormal_body_temperature | 0.65067235 |
| 146 | MP0003329_amyloid_beta_deposits | 0.64000653 |
| 147 | MP0002136_abnormal_kidney_physiology | 0.62571738 |
| 148 | MP0001661_extended_life_span | 0.62113949 |
| 149 | MP0005334_abnormal_fat_pad | 0.60785435 |
| 150 | MP0003690_abnormal_glial_cell | 0.59525542 |
| 151 | MP0006035_abnormal_mitochondrial_morpho | 0.57918846 |
| 152 | MP0000639_abnormal_adrenal_gland | 0.57219024 |
| 153 | MP0009384_cardiac_valve_regurgitation | 0.56675983 |
| 154 | MP0003638_abnormal_response/metabolism_ | 0.54776497 |
| 155 | MP0005666_abnormal_adipose_tissue | 0.51030018 |
| 156 | MP0005395_other_phenotype | 0.49699630 |
| 157 | MP0002928_abnormal_bile_duct | 0.49447211 |
| 158 | MP0005448_abnormal_energy_balance | 0.48953779 |
| 159 | MP0009672_abnormal_birth_weight | 0.47637154 |
| 160 | MP0003953_abnormal_hormone_level | 0.43002700 |
| 161 | MP0005248_abnormal_Harderian_gland | 0.42964461 |
| 162 | MP0003718_maternal_effect | 0.42780659 |
| 163 | MP0004264_abnormal_extraembryonic_tissu | 0.42464431 |
| 164 | MP0001765_abnormal_ion_homeostasis | 0.40162342 |
| 165 | MP0008872_abnormal_physiological_respon | 0.39915367 |
| 166 | MP0002796_impaired_skin_barrier | 0.38886106 |
| 167 | MP0008874_decreased_physiological_sensi | 0.38806190 |
| 168 | MP0003075_altered_response_to | 0.38615071 |
| 169 | MP0002168_other_aberrant_phenotype | 0.37907112 |
| 170 | MP0008873_increased_physiological_sensi | 0.36131118 |
| 171 | MP0000230_abnormal_systemic_arterial | 0.35307475 |
| 172 | MP0005166_decreased_susceptibility_to | 0.34763394 |
| 173 | MP0002135_abnormal_kidney_morphology | 0.33347626 |
| 174 | MP0005058_abnormal_lysosome_morphology | 0.32886756 |
| 175 | MP0010234_abnormal_vibrissa_follicle | 0.32615194 |
| 176 | MP0002822_catalepsy | 0.32431351 |
| 177 | MP0004782_abnormal_surfactant_physiolog | 0.31882397 |
| 178 | MP0000579_abnormal_nail_morphology | 0.31312377 |
| 179 | MP0005167_abnormal_blood-brain_barrier | 0.30293677 |
| 180 | MP0009115_abnormal_fat_cell | 0.30213225 |
| 181 | MP0003959_abnormal_lean_body | 0.29493184 |
| 182 | MP0002970_abnormal_white_adipose | 0.29425772 |
| 183 | MP0002269_muscular_atrophy | 0.28103033 |
| 184 | MP0002837_dystrophic_cardiac_calcinosis | 0.26631480 |
| 185 | MP0001944_abnormal_pancreas_morphology | 0.26490516 |
| 186 | MP0002060_abnormal_skin_morphology | 0.24892442 |
| 187 | MP0001243_abnormal_dermal_layer | 0.23917018 |
| 188 | MP0000538_abnormal_urinary_bladder | 0.23126354 |
| 189 | MP0001881_abnormal_mammary_gland | 0.22847816 |
| 190 | MP0005595_abnormal_vascular_smooth | 0.22713617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.23212052 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.09630268 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.98281027 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.54172122 |
| 5 | Xanthomatosis (HP:0000991) | 6.05292149 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.04075290 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.83227428 |
| 8 | Complement deficiency (HP:0004431) | 5.14104250 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.05365211 |
| 10 | Hyperglycinemia (HP:0002154) | 4.84170197 |
| 11 | Hyperammonemia (HP:0001987) | 4.80961437 |
| 12 | Hyperglycinuria (HP:0003108) | 4.61213683 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.54464148 |
| 14 | Ketosis (HP:0001946) | 4.52615769 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.50884245 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.47055079 |
| 17 | Abnormality of glycine metabolism (HP:0010895) | 4.47055079 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.40378574 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.27762936 |
| 20 | Joint hemorrhage (HP:0005261) | 4.22067789 |
| 21 | Epidermoid cyst (HP:0200040) | 4.16882788 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15352800 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 4.13957103 |
| 24 | Fat malabsorption (HP:0002630) | 4.13629791 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.07716536 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.97128279 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.88672160 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83089766 |
| 29 | Abnormality of complement system (HP:0005339) | 3.70231886 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67656095 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.51709641 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.42120323 |
| 33 | Delayed CNS myelination (HP:0002188) | 3.41574725 |
| 34 | Ketoacidosis (HP:0001993) | 3.39797554 |
| 35 | Gout (HP:0001997) | 3.36434149 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35191566 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.31401532 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.29919611 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.25963204 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.21846870 |
| 41 | Steatorrhea (HP:0002570) | 3.21669721 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 3.03334533 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.00125027 |
| 44 | Metabolic acidosis (HP:0001942) | 2.86088992 |
| 45 | Spastic diplegia (HP:0001264) | 2.76067652 |
| 46 | Lethargy (HP:0001254) | 2.75477029 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.72923531 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72923531 |
| 49 | Vascular calcification (HP:0004934) | 2.71398358 |
| 50 | Pancreatic cysts (HP:0001737) | 2.70503082 |
| 51 | Pancreatic fibrosis (HP:0100732) | 2.70273590 |
| 52 | Myocardial infarction (HP:0001658) | 2.69621899 |
| 53 | True hermaphroditism (HP:0010459) | 2.67251714 |
| 54 | Skin nodule (HP:0200036) | 2.66841134 |
| 55 | Septo-optic dysplasia (HP:0100842) | 2.64373382 |
| 56 | Spontaneous abortion (HP:0005268) | 2.63962081 |
| 57 | Abnormality of the labia minora (HP:0012880) | 2.63466108 |
| 58 | Colon cancer (HP:0003003) | 2.63179405 |
| 59 | Malnutrition (HP:0004395) | 2.56178651 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.55564450 |
| 61 | Anophthalmia (HP:0000528) | 2.50929254 |
| 62 | Neonatal onset (HP:0003623) | 2.50465779 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.47224669 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.43851668 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.43201209 |
| 66 | Irritability (HP:0000737) | 2.41391744 |
| 67 | Late onset (HP:0003584) | 2.39801093 |
| 68 | Cerebral edema (HP:0002181) | 2.39309172 |
| 69 | Esophageal atresia (HP:0002032) | 2.35998233 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.34107634 |
| 71 | Coronal craniosynostosis (HP:0004440) | 2.32845203 |
| 72 | Bilateral microphthalmos (HP:0007633) | 2.32075482 |
| 73 | Abnormality of midbrain morphology (HP:0002418) | 2.31768434 |
| 74 | Molar tooth sign on MRI (HP:0002419) | 2.31768434 |
| 75 | Abnormal gallbladder morphology (HP:0012437) | 2.29847930 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.29337668 |
| 77 | Cholelithiasis (HP:0001081) | 2.26973022 |
| 78 | Enlarged kidneys (HP:0000105) | 2.26452787 |
| 79 | Proximal tubulopathy (HP:0000114) | 2.26012299 |
| 80 | Preaxial foot polydactyly (HP:0001841) | 2.23404265 |
| 81 | Abnormal gallbladder physiology (HP:0012438) | 2.22873430 |
| 82 | Cholecystitis (HP:0001082) | 2.22873430 |
| 83 | Increased purine levels (HP:0004368) | 2.21329383 |
| 84 | Hyperuricemia (HP:0002149) | 2.21329383 |
| 85 | Vomiting (HP:0002013) | 2.20903182 |
| 86 | Esophageal varix (HP:0002040) | 2.20817413 |
| 87 | Hydroxyprolinuria (HP:0003080) | 2.19991120 |
| 88 | Abnormality of proline metabolism (HP:0010907) | 2.19991120 |
| 89 | Mitral stenosis (HP:0001718) | 2.19236973 |
| 90 | Pancreatitis (HP:0001733) | 2.19183810 |
| 91 | Alkalosis (HP:0001948) | 2.17276940 |
| 92 | Acanthocytosis (HP:0001927) | 2.16758506 |
| 93 | Rickets (HP:0002748) | 2.15128752 |
| 94 | Glomerulonephritis (HP:0000099) | 2.12699705 |
| 95 | Nephronophthisis (HP:0000090) | 2.11387742 |
| 96 | Birth length less than 3rd percentile (HP:0003561) | 2.10154963 |
| 97 | Brushfield spots (HP:0001088) | 2.07270040 |
| 98 | Meckel diverticulum (HP:0002245) | 2.06191636 |
| 99 | Partial duplication of thumb phalanx (HP:0009944) | 2.04683826 |
| 100 | Opisthotonus (HP:0002179) | 2.04452764 |
| 101 | Preaxial hand polydactyly (HP:0001177) | 2.03500634 |
| 102 | Absent radius (HP:0003974) | 2.00819266 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 1.99785489 |
| 104 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99711626 |
| 105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99531535 |
| 106 | Patellar aplasia (HP:0006443) | 1.97081225 |
| 107 | Gastrointestinal atresia (HP:0002589) | 1.97045424 |
| 108 | Medial flaring of the eyebrow (HP:0010747) | 1.96750665 |
| 109 | Abnormality of the ileum (HP:0001549) | 1.95916402 |
| 110 | Amyloidosis (HP:0011034) | 1.95426950 |
| 111 | Triphalangeal thumb (HP:0001199) | 1.95283419 |
| 112 | Optic nerve hypoplasia (HP:0000609) | 1.94956109 |
| 113 | Aplasia involving forearm bones (HP:0009822) | 1.94290200 |
| 114 | Absent forearm bone (HP:0003953) | 1.94290200 |
| 115 | Cystic liver disease (HP:0006706) | 1.93713580 |
| 116 | Back pain (HP:0003418) | 1.93302943 |
| 117 | Anencephaly (HP:0002323) | 1.93262284 |
| 118 | Abnormality of the gallbladder (HP:0005264) | 1.92464457 |
| 119 | Sclerocornea (HP:0000647) | 1.92107735 |
| 120 | Vaginal atresia (HP:0000148) | 1.91697986 |
| 121 | Partial duplication of the phalanx of hand (HP:0009999) | 1.91558024 |
| 122 | Genital tract atresia (HP:0001827) | 1.91038123 |
| 123 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.90437296 |
| 124 | Bifid tongue (HP:0010297) | 1.90436921 |
| 125 | Cutaneous finger syndactyly (HP:0010554) | 1.89765882 |
| 126 | Hypophosphatemic rickets (HP:0004912) | 1.89520359 |
| 127 | Thrombophlebitis (HP:0004418) | 1.87002751 |
| 128 | Aplasia involving bones of the extremities (HP:0009825) | 1.85750384 |
| 129 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.85750384 |
| 130 | Aplasia of the phalanges of the hand (HP:0009802) | 1.85750384 |
| 131 | Rib fusion (HP:0000902) | 1.85589470 |
| 132 | Pendular nystagmus (HP:0012043) | 1.84712726 |
| 133 | Gait imbalance (HP:0002141) | 1.84404444 |
| 134 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.83440384 |
| 135 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.83048672 |
| 136 | Glycosuria (HP:0003076) | 1.82934470 |
| 137 | Abnormality of urine glucose concentration (HP:0011016) | 1.82934470 |
| 138 | Abnormality of vitamin metabolism (HP:0100508) | 1.82761845 |
| 139 | Menorrhagia (HP:0000132) | 1.82135869 |
| 140 | Hemorrhage of the eye (HP:0011885) | 1.81079296 |
| 141 | Supernumerary spleens (HP:0009799) | 1.80895232 |
| 142 | Ectopic kidney (HP:0000086) | 1.80891219 |
| 143 | Chronic hepatic failure (HP:0100626) | 1.80120063 |
| 144 | Confusion (HP:0001289) | 1.80022518 |
| 145 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.79392450 |
| 146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79034160 |
| 147 | Congenital primary aphakia (HP:0007707) | 1.78971216 |
| 148 | Abnormal lung lobation (HP:0002101) | 1.78679800 |
| 149 | Abnormality of the renal medulla (HP:0100957) | 1.77131209 |
| 150 | Cerebellar dysplasia (HP:0007033) | 1.77107668 |
| 151 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76781890 |
| 152 | Absent septum pellucidum (HP:0001331) | 1.76544315 |
| 153 | Congenital, generalized hypertrichosis (HP:0004540) | 1.76095347 |
| 154 | Intestinal atresia (HP:0011100) | 1.75792631 |
| 155 | Broad foot (HP:0001769) | 1.75378476 |
| 156 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75026702 |
| 157 | Chromsome breakage (HP:0040012) | 1.73920005 |
| 158 | Occipital encephalocele (HP:0002085) | 1.71580934 |
| 159 | Type II lissencephaly (HP:0007260) | 1.71394546 |
| 160 | Postaxial foot polydactyly (HP:0001830) | 1.70219286 |
| 161 | Maternal diabetes (HP:0009800) | 1.69987572 |
| 162 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.68418606 |
| 163 | Dandy-Walker malformation (HP:0001305) | 1.67664122 |
| 164 | Stenosis of the external auditory canal (HP:0000402) | 1.67257311 |
| 165 | Duplication of thumb phalanx (HP:0009942) | 1.66751387 |
| 166 | Abnormality of alanine metabolism (HP:0010916) | 1.66572405 |
| 167 | Hyperalaninemia (HP:0003348) | 1.66572405 |
| 168 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.66572405 |
| 169 | Short hallux (HP:0010109) | 1.66303918 |
| 170 | Hepatoblastoma (HP:0002884) | 1.65751095 |
| 171 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.65709764 |
| 172 | Cutaneous syndactyly (HP:0012725) | 1.64116379 |
| 173 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.62647970 |
| 174 | Abnormal number of erythroid precursors (HP:0012131) | 1.61847125 |
| 175 | Abnormal biliary tract physiology (HP:0012439) | 1.61640561 |
| 176 | Bile duct proliferation (HP:0001408) | 1.61640561 |
| 177 | Renal hypoplasia (HP:0000089) | 1.61637334 |
| 178 | Hypoplasia of the ulna (HP:0003022) | 1.61431986 |
| 179 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.59634215 |
| 180 | Reticulocytopenia (HP:0001896) | 1.57755060 |
| 181 | Tubular atrophy (HP:0000092) | 1.55518984 |
| 182 | Oligodactyly (hands) (HP:0001180) | 1.54756118 |
| 183 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.54612212 |
| 184 | Methylmalonic acidemia (HP:0002912) | 1.54043591 |
| 185 | Abnormal number of incisors (HP:0011064) | 1.53927282 |
| 186 | Postaxial hand polydactyly (HP:0001162) | 1.53664273 |
| 187 | Nephrogenic diabetes insipidus (HP:0009806) | 1.53583603 |
| 188 | Labial hypoplasia (HP:0000066) | 1.53442132 |
| 189 | Hypoplastic female external genitalia (HP:0012815) | 1.52924002 |
| 190 | Hypoplasia of the pons (HP:0012110) | 1.50413874 |
| 191 | Lissencephaly (HP:0001339) | 1.46533067 |
| 192 | Holoprosencephaly (HP:0001360) | 1.46037600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.94116634 |
| 2 | ERN1 | 4.49666506 |
| 3 | SIK1 | 4.38672224 |
| 4 | FGFR4 | 3.85364559 |
| 5 | PKN2 | 2.78861110 |
| 6 | TRIB3 | 2.77538203 |
| 7 | MKNK2 | 2.57644816 |
| 8 | ERBB4 | 2.56213812 |
| 9 | CDC7 | 2.51443634 |
| 10 | BMPR1B | 2.35936185 |
| 11 | MKNK1 | 2.26865213 |
| 12 | INSRR | 2.24623294 |
| 13 | ZAK | 2.17042185 |
| 14 | PNCK | 2.16553036 |
| 15 | MAP2K4 | 2.16523549 |
| 16 | CASK | 2.15317882 |
| 17 | BUB1 | 2.10069936 |
| 18 | TAOK3 | 2.09765528 |
| 19 | LATS1 | 2.04087128 |
| 20 | VRK2 | 2.00639799 |
| 21 | TNIK | 1.96717986 |
| 22 | TTK | 1.85118440 |
| 23 | FLT3 | 1.83023863 |
| 24 | STK38L | 1.81088226 |
| 25 | PBK | 1.79962953 |
| 26 | MAPK11 | 1.79526244 |
| 27 | WEE1 | 1.79008659 |
| 28 | BRSK2 | 1.74967233 |
| 29 | PLK3 | 1.69537714 |
| 30 | MST1R | 1.63476340 |
| 31 | PTK6 | 1.61678409 |
| 32 | DYRK2 | 1.60922428 |
| 33 | PIK3CG | 1.50702280 |
| 34 | ACVR1B | 1.46656675 |
| 35 | SRPK1 | 1.45564908 |
| 36 | MARK1 | 1.44714597 |
| 37 | DAPK2 | 1.42554717 |
| 38 | NEK2 | 1.28866811 |
| 39 | ABL2 | 1.28668701 |
| 40 | VRK1 | 1.28094912 |
| 41 | TAF1 | 1.26379680 |
| 42 | NEK9 | 1.25814124 |
| 43 | PLK4 | 1.25760508 |
| 44 | FRK | 1.22176953 |
| 45 | PINK1 | 1.21816840 |
| 46 | WNK4 | 1.20589213 |
| 47 | TSSK6 | 1.20104863 |
| 48 | GRK1 | 1.19021689 |
| 49 | PLK1 | 1.18756926 |
| 50 | MAP3K7 | 1.17696334 |
| 51 | TGFBR1 | 1.15590919 |
| 52 | MAP4K2 | 1.13818980 |
| 53 | MAP3K10 | 1.13628495 |
| 54 | NUAK1 | 1.12772459 |
| 55 | RIPK1 | 1.09852006 |
| 56 | WNK3 | 1.09042939 |
| 57 | NEK1 | 1.08198351 |
| 58 | ERBB2 | 1.08041281 |
| 59 | TYK2 | 1.07364907 |
| 60 | FGFR2 | 1.04626246 |
| 61 | ADRBK2 | 1.04533463 |
| 62 | MET | 1.02943304 |
| 63 | PLK2 | 1.02556031 |
| 64 | BRSK1 | 1.01733231 |
| 65 | STK3 | 1.01591348 |
| 66 | STK39 | 0.99487098 |
| 67 | KDR | 0.99013761 |
| 68 | LATS2 | 0.98142179 |
| 69 | PDK3 | 0.96872860 |
| 70 | PDK4 | 0.96872860 |
| 71 | CHEK2 | 0.96076300 |
| 72 | JAK2 | 0.95837380 |
| 73 | PRKAA2 | 0.95481758 |
| 74 | NME1 | 0.93359636 |
| 75 | TRIM28 | 0.86903475 |
| 76 | MAP2K3 | 0.86304793 |
| 77 | NTRK2 | 0.86301393 |
| 78 | PTK2 | 0.85521076 |
| 79 | CDK6 | 0.84699155 |
| 80 | PRKCZ | 0.84367295 |
| 81 | STK16 | 0.83901970 |
| 82 | BCR | 0.83899563 |
| 83 | EPHA4 | 0.76882908 |
| 84 | GRK6 | 0.76821690 |
| 85 | PASK | 0.76420171 |
| 86 | ATR | 0.76091732 |
| 87 | TIE1 | 0.76075301 |
| 88 | MAPK12 | 0.76057252 |
| 89 | DYRK1B | 0.75798417 |
| 90 | MAP3K4 | 0.75615426 |
| 91 | MAP3K3 | 0.73632143 |
| 92 | NTRK1 | 0.73416487 |
| 93 | CSNK1G2 | 0.70961319 |
| 94 | CAMK1G | 0.70896329 |
| 95 | PDGFRA | 0.70184006 |
| 96 | MAPK4 | 0.69633108 |
| 97 | MAP2K6 | 0.67958070 |
| 98 | DYRK3 | 0.67380794 |
| 99 | PRKAA1 | 0.66451207 |
| 100 | CDK19 | 0.65919433 |
| 101 | CAMK1D | 0.65530995 |
| 102 | MAP3K11 | 0.65000321 |
| 103 | PRKACG | 0.64765386 |
| 104 | CSNK1A1L | 0.64702000 |
| 105 | TYRO3 | 0.62655178 |
| 106 | AURKB | 0.62462898 |
| 107 | GSK3A | 0.61979347 |
| 108 | SGK3 | 0.61195259 |
| 109 | PRKCE | 0.60944430 |
| 110 | CSNK1G3 | 0.59913286 |
| 111 | CSNK1E | 0.59320451 |
| 112 | MTOR | 0.59012486 |
| 113 | MAPK13 | 0.58664279 |
| 114 | MAPK15 | 0.57682094 |
| 115 | STK38 | 0.57464481 |
| 116 | TAOK2 | 0.56102389 |
| 117 | CAMK2G | 0.55252684 |
| 118 | MAP2K1 | 0.54924901 |
| 119 | ATM | 0.54428237 |
| 120 | ADRBK1 | 0.54396628 |
| 121 | OXSR1 | 0.54033008 |
| 122 | PHKG1 | 0.53357005 |
| 123 | PHKG2 | 0.53357005 |
| 124 | PDK2 | 0.53117701 |
| 125 | CDK4 | 0.51373365 |
| 126 | RET | 0.51130484 |
| 127 | MAP2K7 | 0.50816779 |
| 128 | JAK1 | 0.50755915 |
| 129 | SGK494 | 0.49961983 |
| 130 | SGK223 | 0.49961983 |
| 131 | TLK1 | 0.49683541 |
| 132 | CSNK1A1 | 0.49517046 |
| 133 | MAPKAPK5 | 0.48969374 |
| 134 | TBK1 | 0.48717521 |
| 135 | AURKA | 0.48488987 |
| 136 | TGFBR2 | 0.48418217 |
| 137 | CDK3 | 0.48369360 |
| 138 | DYRK1A | 0.48308855 |
| 139 | UHMK1 | 0.47958251 |
| 140 | PDPK1 | 0.47943807 |
| 141 | BMX | 0.47739393 |
| 142 | MAP2K2 | 0.47670875 |
| 143 | ICK | 0.44723297 |
| 144 | FGFR1 | 0.43759668 |
| 145 | MAPK7 | 0.43741075 |
| 146 | FER | 0.43543702 |
| 147 | PRKDC | 0.42375692 |
| 148 | NTRK3 | 0.42320530 |
| 149 | CDK1 | 0.41927609 |
| 150 | SGK2 | 0.40289728 |
| 151 | PRKCG | 0.39700252 |
| 152 | CHEK1 | 0.39397996 |
| 153 | PRKCI | 0.37788261 |
| 154 | CAMK2A | 0.37742222 |
| 155 | IGF1R | 0.35907627 |
| 156 | EPHB1 | 0.35688454 |
| 157 | MAP3K5 | 0.35378023 |
| 158 | PAK3 | 0.35347920 |
| 159 | MAP3K2 | 0.34004156 |
| 160 | MAP3K6 | 0.30166109 |
| 161 | EPHA2 | 0.29993483 |
| 162 | AKT2 | 0.29853078 |
| 163 | LRRK2 | 0.29642796 |
| 164 | IRAK3 | 0.27908238 |
| 165 | CSK | 0.27605039 |
| 166 | AKT3 | 0.26925546 |
| 167 | CSNK1G1 | 0.26853769 |
| 168 | CAMK4 | 0.26625689 |
| 169 | KSR2 | 0.26052831 |
| 170 | EGFR | 0.25820601 |
| 171 | PDK1 | 0.25629992 |
| 172 | EPHB2 | 0.24241229 |
| 173 | PAK2 | 0.23991242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.35620877 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.76224358 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39280417 |
| 4 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.17155990 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07533789 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81799392 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62407226 |
| 8 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.61644163 |
| 9 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56479612 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.52017762 |
| 11 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.49891592 |
| 12 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49726148 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26340950 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25982328 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.18084351 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.11616400 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02858072 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89082368 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84827043 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84811937 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.84653429 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84633573 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82128940 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.79417993 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.75266756 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.68326695 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67296641 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64936785 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64248472 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63947980 |
| 31 | Mismatch repair_Homo sapiens_hsa03430 | 1.63075218 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62631605 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59218033 |
| 34 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59115076 |
| 35 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.55752119 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.53417632 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.51656405 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51177607 |
| 39 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.49116790 |
| 40 | Ribosome_Homo sapiens_hsa03010 | 1.45342890 |
| 41 | DNA replication_Homo sapiens_hsa03030 | 1.44794428 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43594527 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.42142745 |
| 44 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.42075632 |
| 45 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41382858 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37025935 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.36234124 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35993409 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35582185 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34748969 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.34686540 |
| 52 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31918539 |
| 53 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.30736382 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30456595 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30337327 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28995280 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23275248 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 1.18864842 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18630249 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18567454 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 1.17569084 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.15356223 |
| 63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.15283589 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13971191 |
| 65 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.13373946 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 1.12479496 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09011912 |
| 68 | Huntingtons disease_Homo sapiens_hsa05016 | 1.07595191 |
| 69 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.06965511 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 1.05046729 |
| 71 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.02584001 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01063246 |
| 73 | Base excision repair_Homo sapiens_hsa03410 | 1.00906781 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00352926 |
| 75 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98291842 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95553854 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95399393 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.94645269 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93040450 |
| 80 | Spliceosome_Homo sapiens_hsa03040 | 0.91612549 |
| 81 | RNA transport_Homo sapiens_hsa03013 | 0.90365267 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88998866 |
| 83 | Cell cycle_Homo sapiens_hsa04110 | 0.88662303 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85781784 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84141090 |
| 86 | Proteasome_Homo sapiens_hsa03050 | 0.83949751 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80971856 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79397531 |
| 89 | * Lysine degradation_Homo sapiens_hsa00310 | 0.77209891 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76703378 |
| 91 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76290965 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75588977 |
| 93 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72307415 |
| 94 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.69980300 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.69136675 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69108788 |
| 97 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67128569 |
| 98 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66787957 |
| 99 | Taste transduction_Homo sapiens_hsa04742 | 0.66060420 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61979888 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61119588 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.60000486 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58847281 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53106352 |
| 105 | Axon guidance_Homo sapiens_hsa04360 | 0.53072562 |
| 106 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.50469556 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.49999313 |
| 108 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47620408 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36018832 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.34787238 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31781879 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25977364 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25118001 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.22893047 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21933105 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17743925 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13286207 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11746796 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10928011 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06313676 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.02911740 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | -0.2250760 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2210130 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2056890 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | -0.2046888 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2043369 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1982728 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1978164 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1724717 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1520848 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1477893 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1160765 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | -0.1136538 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1004971 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0958429 |
| 136 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0895766 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0890797 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0782852 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0489773 |
| 140 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0481788 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0283724 |

